Dr Hutton White, MD | |
1 Genesys Pkwy, Grand Blanc, MI 48439-8065 | |
(270) 839-0743 | |
Not Available |
Full Name | Dr Hutton White |
---|---|
Gender | Male |
Speciality | Student In An Organized Health Care Education/training Program |
Location | 1 Genesys Pkwy, Grand Blanc, Michigan |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1154942415 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208600000X | Surgery | 4351046041 (Michigan) | Secondary |
390200000X | Student In An Organized Health Care Education/training Program | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Hutton White, MD 1 Genesys Pkwy, Grand Blanc, MI 48439-8065 Ph: () - | Dr Hutton White, MD 1 Genesys Pkwy, Grand Blanc, MI 48439-8065 Ph: (270) 839-0743 |
News Archive
A change in evidence-based guidelines for vasectomy may have led to a reduction in the number of follow-up tests to confirm the procedure was successful, reports a study in Urology Practice®, an Official Journal of the American Urological Association (AUA). The journal is published in the Lippincott portfolio by Wolters Kluwer.
Pfizer Inc. announced today that it has stopped a Phase 3 clinical trial of Lyrica (pregabalin) in patients with neuropathic pain associated with HIV neuropathy, a form of nerve damage characterized by burning pain usually beginning in the feet. The decision follows review of a planned interim analysis of the study by the trial's external Data Monitoring Committee.
WebMD Health Corp. announced today the final results of its tender offer to purchase up to 5,800,000 shares of its common stock at a price of $46.80 per share, which expired at 5:00 p.m., New York City time on April 8, 2010. Based on the final tabulation by American Stock Transfer & Trust Company, the Depositary for the tender offer, 5,172,204 shares of WebMD common stock were properly tendered and delivered.
"A paper published in Nature on Monday sheds light on how a vaccine can turn the immune system against [HIV] and so offer protection from infection," Nature News reports, noting "[t]he results are also being presented at the AIDS Vaccine 2012 conference in Boston, Massachusetts, this week."
New research from the University of New South Wales shows some people may repeatedly be able to clear hepatitis C virus from their bodies, without any biological traces of the potentially serious infection.
› Verified 7 days ago